Doxorubicin Hydrochloride
- Product NDC
- 0069-4033
- 11-digit product format
- 000694033
- Labeler code
- 0069
- Product ID
- 0069-4033_81a2dcea-14b8-43d2-a818-21edd9fc4f12
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxorubicin Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- NDA050629
- Marketing category
- NDA
- Marketing start
- 2013-03-05
- Marketing end
- 0000-00-00
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [CS],Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0069-4033-01 | 00069403301 | 1 VIAL, MULTI-DOSE in 1 PACKAGE (0069-4033-01) > 75 mL in 1 VIAL, MULTI-DOSE | 2013-03-05 | 0000-00-00 | No | No | Current |